Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Growth
Geographical Focus
United States, Canada, Israel
Industries Focus
- Technology
- Life Sciences
- Agrifoodtech
Investment Size:
500,000 to 2,000,000 USD
Investor Details Founded: 1996
Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities, Inc., focusing on investing in transformative life science, agrifoodtech, and technology companies. Since its inception in 1996, the firm has been dedicated to advancing human health by supporting companies developing innovative therapies and technologies. The firm has a longstanding track record of investing in early-stage companies that are pioneering cutting-edge therapeutic platforms and technologies.
The firm's investment strategy emphasizes seed, early, and growth-stage companies that are at the forefront of innovation in life sciences and technology. Alexandria Venture Investments has been recognized for its active role in the agrifoodtech sector, ranking among the top five most active U.S.-based investors in this field for multiple consecutive years. This recognition underscores the firm's commitment to supporting companies that are developing sustainable solutions to address global challenges in food security and climate change.
With a focus on sectors such as life sciences, agrifoodtech, and technology, Alexandria Venture Investments aims to partner with trailblazing companies to drive transformative innovation. The firm's investments are guided by a mission to improve human health, nutrition, and sustainability by backing companies developing disruptive technologies and therapies. This approach reflects Alexandria Venture Investments' dedication to fostering innovation that has a meaningful impact on society and the global economy.
Requirements
- Innovative technologies
- Early-stage companies
- Focus on life sciences and technology sectors
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Alnylam Pharmaceuticals
- Intra-Cellular Therapies
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$14.95
Claim this Investor
Are you an official representative of Alexandria Venture Investments?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim